SureTrader
Home > Boards > US Listed > Biotechs > NorthWest Biotherapeutics (NWBO)

Here is the link to Germany DCVax Clinical

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
john1045 Member Profile
 
Followed By 23
Posts 1,812
Boards Moderated 0
Alias Born 06/09/11
160x600 placeholder
Advertisement
Undervalued and Underexposed NYSE-MKT Stock to be Profiled by Large Media Group and four brief reports "InvestorsHub NewsWire" - 6/15/2015 7:00:00 AM
/C O R R E C T I O N -- Northwest Biotherapeutics, Inc./ "PR Newswire (US)" - 6/1/2015 11:44:00 AM
NW Bio Announces Data to Date From DCVax®-Direct Phase I Trial "PR Newswire (US)" - 6/1/2015 10:33:00 AM
NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend "PR Newswire (US)" - 5/27/2015 8:30:00 AM
NW Bio To Present At New York Academy Of Sciences' Conference On Emerging Approaches To Immunotherapy "PR Newswire (US)" - 5/21/2015 10:56:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/11/2015 5:52:34 PM
NW Bio Closes On $28.5 Million Second Tranche Of Woodford $40 Million Financing "PR Newswire (US)" - 5/1/2015 10:54:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/30/2015 3:57:50 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/30/2015 3:56:32 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/30/2015 3:54:47 PM
NW Bio Featured In Presentations At the American Association for Cancer Research Annual Meeting "PR Newswire (US)" - 4/20/2015 6:00:00 AM
NW Bio Included In New Index Of The "Top 25 Cancer Immunotherapy Companies" "PR Newswire (US)" - 4/16/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/14/2015 1:50:12 PM
NW BIO TO PRESENT AT WORLD VACCINE CONGRESS 2015 "PR Newswire (US)" - 4/9/2015 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/8/2015 5:13:56 PM
CapRock Research Issues Analyst Report on Avra, Inc. (OTCQB: AVRN): Pioneering Product Innovation in Growing Bitcoin Market "InvestorsHub NewsWire" - 4/8/2015 8:00:00 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 4/7/2015 5:03:44 PM
Disruptive Innovation Changing the Fight Against Cancer "The Motley Fool" - 4/5/2015 1:02:02 PM
NW Bio Announces $40 Million Financing "PR Newswire (US)" - 4/2/2015 11:55:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/30/2015 6:04:35 AM
NW BIO REPORTS PROMISING SURVIVAL DATA IN 51 GBM PATIENTS TREATED WITH DCVAX®-L "PR Newswire (US)" - 3/27/2015 9:00:00 AM
NW Bio To Present At The 2nd Immunotherapy Of Cancer Conference, ITOC-2 "PR Newswire (US)" - 3/24/2015 10:42:00 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/17/2015 9:51:26 AM
Notification That Annual Report Will Be Submitted Late (nt 10-k) "Edgar (US Regulatory)" - 3/16/2015 5:22:38 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/23/2015 4:53:17 PM
john1045   Monday, 12/24/12 04:47:16 PM
Re: None
Post # of 37073 
Here is the link to Germany DCVax Clinical trials with an area I pasted from long report so they obviously are recruiting over there as of now....

http://translate.google.com/translate?hl=en&sl=de&u=http://www.uniklinik-duesseldorf.de/fileadmin/Datenpool/einrichtungen/universitaetstumorzentrum_id505/neu2012/Dateien/Klinische_Studien_UTZ_Duesseldorf.pdf&prev=/search%3Fq%3Ddcvax%26start%3D50%26hl%3Den%26sa%3DN%26tbo%3Dd%26biw%3D1366%26bih%3D586%26tbs%3Dqdr:w&sa=X&ei=I8nYULiqM7GH0QGx6oDACg&ved=0CGwQ7gEwCTgy

Page 11 of 23

Clinical trials in brain tumors


IND No. 10206

Glioblastoma (brain cancer)

Phase II clinical trial to evaluate DCVax-Brain, autologous dendritic cells pulsed with tumor lysate, for treatment

of glioblastoma multiforme.



A Phase II Clinical Trial Evaluating DCVax-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate for the Treatment of Glioblastoma

Multiforme

Your contact:

Prof. Dr. Michael Sabel

Michael.Sabel @ med.uni-duesseldorf.de



Page 12


Current clinical studies at University Cancer Center UTZ

University Cancer Center UTZ

Info Phone: 0211-8108200

at the University Hospital Dusseldorf

www.uniklinik-duesseldorf.de/utz

Stand: 01/2013

Page 12 of 23

Clinical trials in brain tumors

Fraunhofer Institute

Glioblastoma (brain cancer)

Phase II clinical study evaluating DCVax ®-L Brain autologous dendritic cells loaded with tumor lysate antigen for

Treatment of glioblastoma multiforme (GBM)

Clinical phase II trial to evaluate DCVax ®-L Brain autologous dendritic cells loaded with tumor lysate antigen for treatment of glioblastoma

multiforme (GBM)

Your contact:

Infoline

Tel: 0211-8108200

uta@med.uni-duesseldorf.de


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist